🇮🇹·22h agoIndustry
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA +5.0%, ADJUSTED NET INCOME +7.2%
Publisher
R
Recordati
Italy
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on recordati.com
Leave the platform to read the original full article on the publisher site.
Source: Recordati
Scope: Industry
Related coverage
More related coverage
Sumitomo Pharma·11h ago
Sumitomo Pharma Announces Personnel Changes
Cibeles (Uruguay)·14h ago
GLIFOWEED PLATINUM
Natco Pharma·15h ago
natco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26
Natco Pharma·15h ago